Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 November 2021 | Story Dr Nitha Ramnath | Photo Supplied


“Running provides me with a platform to reach others, to bring hope, to make people realise that anything is possible if you are prepared to work hard for it,” says Louzanne Coetzee, our very own home-grown all-round achiever, who is fun-loving, relatable, and inspiring. A South African para-athlete, Coetzee was born blind as a result of a hereditary condition called Leber congenital amaurosis, and competes in the T11 disability class for athletes with the highest level of visual impairment. Coetzee enjoys an integrated life, with an interest in baking, watching movies, walking and hiking, cycling, being part of a church band, public speaking, coupled with some artistic hobbies.

Our podcast guest

Coetzee competed at the 2020 Tokyo Paralympic Games this year, where she won a silver medal in the 1 500 m final alongside her guide Erasmus Badenshorst, setting a new African record of 4:40.96. She also competed in the women’s mixed class marathon (T11 and T12 for the visually impaired) with her guide Claus Kempen, improving the world record by 1 min 42 sec and her personal best from 3:13:41 to 3:11:13. 

In 2018, Coetzee competed in three events at the Para Athletics event in Berlin, Germany – the 800 m, 1 500 m, and 5 000 m. She set a new African record in the T11 800 m race, taking the silver medal, as well as a bronze for the 1 500 m race. In 2018, Coetzee also broke the 5 000 m (women) world record in her disability class, while in the same year she became the first visually impaired athlete to compete at the World University Cross Country Championships in Switzerland. 
Coetzee set a new world record in the 5 000 m T11 category for the first time at the Nedbank National Championships for the Physically Disabled in March 2016. Moreover, with her performance of 19:17.06, Coetzee shattered the Lithuanian athlete Sigita Markeviciene’s 16-year record of 20:05.81, set at the 2000 Paralympics in Sydney. Coetzee became the first totally blind female to clock sub-20 minutes in the 5 000 m.

Her involvement in her society stretches beyond sports, and as a student, she formed part of the University of the Free State Student Representative Council. She was also an athlete representative on the Free State Academy of Sport’s executive committee.

In 2014, she became the first visually impaired student to be elected to the UFS Student Representative Council (SRC), with the portfolio Student Accessibility. From 2015 to 2017, she was a research assistant in the Institute for Reconciliation and Social Justice at the UFS, and in 2016 she also acted as junior lecturer in a computer module for students with visual impairments. From 2017 to 2018, she was Residence Head of Arista Ladies City Residence, and she is currently the Residence Head of Akasia Residence at the UFS.  

Coetzee boasts several accolades from the UFS. She was named the 2014 Senior Sportswoman of the Year by the Free State Sport Association for the Physically Disabled (FSSAPD). In 2017, she and her guide Khothatso Mokone received a Special Award for Disabled Sport at the KovsieSport Awards. In 2018, she won the Free State Sports Star Award, and was named Sports Star of the Year (period June 2018 to April 2019) by the Free State Sport Association for the Physically Disabled. 

Coetzee’s academic qualifications include a BA and BAHons in Integrated and Corporative Marketing Communication, and an MA in Social Cohesion and Reconciliation – all from the University of the Free State. 
Listen to the podcast  below

François van Schalkwyk and Keenan Carelse, UFS alumni leading the university’s United Kingdom Alumni Chapter, have put their voices together to produce and direct the podcast series.  Intended to reconnect alumni with the university and their university experience, the podcasts will be featured on the first Monday of every month, ending in November 2021.  Our featured alumni share and reflect on their experiences at the UFS, how it has shaped their lives, and relate why their ongoing association with the UFS is still relevant and important. The podcasts are authentic conversations – they provide an opportunity for the university to understand and learn about the experiences of its alumni and to celebrate the diversity and touchpoints that unite them. 

For further information regarding the podcast series, or to propose other alumni guests, please email us at alumnipodcast@ufs.ac.za 

For all Voices from the Free State podcasts, click here 
    

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept